Weed (BUDZ) Return on Capital Employed Growth (1y) (2019 - 2026)
Weed (BUDZ) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.97 Bn | 87.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.26 Bn | 30.32 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 1,195.00 |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -17,327.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,327.00 |
| Dec 31, 2025 | 583.00 |
| Sep 30, 2025 | -37,360.00 |
| Jun 30, 2025 | 118,312.00 |
| Mar 31, 2025 | 58,896.00 |
| Dec 31, 2024 | 32,115.00 |
| Sep 30, 2024 | 65,119.00 |
| Jun 30, 2024 | -199,171.00 |
| Mar 31, 2024 | 68,088.00 |
| Dec 31, 2023 | 12,349.00 |
| Sep 30, 2023 | 841.00 |
| Jun 30, 2023 | 117,687.00 |
| Mar 31, 2023 | -36,178.00 |
| Dec 31, 2022 | 25,208.00 |
| Sep 30, 2022 | 16,688.00 |
| Jun 30, 2022 | 9,607.00 |
| Mar 31, 2022 | -38,898.00 |
| Dec 31, 2021 | -9,181.00 |
| Sep 30, 2021 | 38,774.00 |
| Jun 30, 2021 | 98,105.00 |